reported their experience with valve replacement in children with mitral insufficiency. They divided their patients in three groups, depending on the type of prosthesis: mechanical valves, porcine xenografts and dura mater valves. Follow up times were 6.3, 3.3 and 1.9 years, with death rates of 1.3%, 14% and 2.3% per patient/year. Thromboembolism, valve dysfunction and infective endocarditis were listed as chief complications.
Mitral Annuloplasty vs Valve Replacement for Mitral Insufficiency
To the Editor:
Attie et al. ' reported their experience with valve replacement in children with mitral insufficiency. They divided their patients in three groups, depending on the type of prosthesis: mechanical valves, porcine xenografts and dura mater valves. Follow up times were 6.3, 3.3 and 1.9 years, with death rates of 1.3%, 14% and 2.3% per patient/year. Thromboembolism, valve dysfunction and infective endocarditis were listed as chief complications.
When advising a patient on surgery, we should strive to present options, weigh risks and benefits. Some mitral valves are so severely diseased that valve replacement is mandatory. However, it is regret- We appreciate the comments of Drs. Thilenius and Replogle on our paper on mitral valve replacement in children. I would like to answer that the paper was directed to the what type of prosthesis should be used for mitral valve replacement in patients under 15 years of age, and not to what surgical procedure is better for these children.
Our experience with mitral annuloplasty is not enough to compare both techniques and their results. The results obtained by Drs. Thilenius and Replogle, as well as those reported by other authors, are encouraging the use of mitral annuloplasty to reduce the problems related to anticoagulant therapy and bioprosthesis calcification.
We do not deny that mitral annuloplasty is of great value, but as I mentioned earlier, the sole purpose of this paper was to report our results on which valvular prosthesis is best for children. On page 702, the sentence beginning on line 26 of the left-hand column should read: An induced increase in heart rate averaging 34 beats/min produced an increase in mean Vcf of 13% in human subjects, and a phenylephrine-induced increase in systolic blood pressure of 38 mm Hg reduced mean Vcf by 21%.
